These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30475926)
1. Device-based treatment for vaginal wellness. Alexiades M Semin Cutan Med Surg; 2018 Dec; 37(4):226-232. PubMed ID: 30475926 [TBL] [Abstract][Full Text] [Related]
2. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
3. The vaginal wellness consultation for treatment with energy-based devices. Miller MD Semin Cutan Med Surg; 2018 Dec; 37(4):233-235. PubMed ID: 30475933 [No Abstract] [Full Text] [Related]
4. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser. Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M; Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104 [TBL] [Abstract][Full Text] [Related]
5. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
6. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
7. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F; DE Seta F; Faoro V; Raichi M Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667 [TBL] [Abstract][Full Text] [Related]
8. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800 [TBL] [Abstract][Full Text] [Related]
9. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T; Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374 [TBL] [Abstract][Full Text] [Related]
10. Vaginal laser therapy for genitourinary syndrome of menopause - systematic review. Mension E; Alonso I; Tortajada M; Matas I; Gómez S; Ribera L; Anglès S; Castelo-Branco C Maturitas; 2022 Feb; 156():37-59. PubMed ID: 34217581 [TBL] [Abstract][Full Text] [Related]
11. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Faubion SS; Sood R; Kapoor E Mayo Clin Proc; 2017 Dec; 92(12):1842-1849. PubMed ID: 29202940 [TBL] [Abstract][Full Text] [Related]
12. Genitourinary syndrome of menopause and the use of laser therapy. Hutchinson-Colas J; Segal S Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234 [TBL] [Abstract][Full Text] [Related]
13. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Portman DJ; Gass ML; Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577 [TBL] [Abstract][Full Text] [Related]
14. Laser Therapy for Genitourinary Syndrome of Menopause. Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032 [TBL] [Abstract][Full Text] [Related]
15. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment. Mothes AR; Runnebaum M; Runnebaum IB J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993 [TBL] [Abstract][Full Text] [Related]
16. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744 [TBL] [Abstract][Full Text] [Related]
17. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Giarenis I; Tsiapakidou S; Zacche M; Mukhopadhyay S; Mahmood T Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():342-344. PubMed ID: 38811292 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235 [TBL] [Abstract][Full Text] [Related]
19. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C; Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644 [TBL] [Abstract][Full Text] [Related]
20. Lasers in the era of evidence-based medicine. Hillard TC Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]